Vanda Pharmaceuticals (VNDA) Tops Q3 EPS by 9c
Tweet
Share
E-mailGet Alerts VNDA Hot Sheet
Price: $5.03 --0%
Financial Fact:
Cost of sales, product: 6.99M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Cost of sales, product: 6.99M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q3 EPS of ($0.11), $0.09 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $28.3 million versus the consensus estimate of $28.84 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vanda Pharmaceuticals (VNDA) PT Lowered to $20 at H.C. Wainwright
- Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
- DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
